Supplementary Information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material
The Phase 2 retatrutide trial (PMID 37366315) reported -24.2% body weight change at the 12 mg weekly dose across 48 weeks
GLP-1 hair loss complete guide discusses this phenomenon in detail
Add it to your cart and check out securely pay by Interac e-Transfer, no account needed
Returning a Product Prior to initiating a change of mind return, please contact VetSupply
In some cases, individuals may also experience regurgitation of food or sour liquid, which can further exacerbate the discomfort and lead to a restless nights sleep